Supernus Pharmaceuticals, Inc.
SUPN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | $22 | -$12 | $15 |
| Dep. & Amort. | $25 | $21 | $20 | $19 |
| Deferred Tax | -$3 | -$7 | -$4 | -$0 |
| Stock-Based Comp. | $8 | $8 | $8 | $8 |
| Change in WC | -$49 | $11 | $14 | -$5 |
| Other Non-Cash | $3 | $3 | $4 | $8 |
| Operating Cash Flow | -$62 | $59 | $31 | $44 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$127 | -$141 | -$119 | -$145 |
| Inv. Sales/Matur. | $469 | $110 | $156 | $133 |
| Other Inv. Act. | -$293 | $0 | $0 | $0 |
| Investing Cash Flow | $49 | -$31 | $37 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $24 | $3 | $2 | $7 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | -$2 | -$23 | -$1 |
| Financing Cash Flow | $21 | $1 | -$21 | $6 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8 | $29 | $47 | $38 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $145 | $116 | $69 | $32 |
| End Cash | $153 | $145 | $116 | $69 |
| Free Cash Flow | -$62 | $58 | $30 | $44 |